Last updated 2026-07-20
- Raised $7M Series B led by Axil Capital, Feb 2021
- Raised $2.5M grant, Dec 2023
- Raised $2.6M Series A led by Johnson & Johnson Innovation, Apr 2019
Total raised
$12.9M
Last: Undisclosed Round 2025-08
Stage
Series B
Founded
2012
Headcount
27
HQ
Rehovot, Israel
Sector
Health Tech & Life Sciences
About
Techsomed is an Israeli medical imaging software company dedicated to enhancing clinical impact in Oncology, Cardiology, and Pain Management through its AI-powered Image Guided Ablation Therapy System. The company's BioTrace platform leverages standard medical imaging (US, CT, MRI) for real-time ablation visualization, advanced patient-specific treatment planning, and predictive procedure analysis to ensure high-precision ablation. Their technology aims to improve the accuracy and efficacy of minimally invasive thermal ablation procedures by providing real-time monitoring and control of tissue destruction. Techsomed operates in Israel, Germany, and Japan.
Funding history · 6 rounds · $12.9M total
2025-07
C Round
Undisclosed
★ NextLeap Ventures
2023-12
Grant
$2.5M
2021-02
B Round
$7.0M
★ Axil CapitalCobro VenturesRadianx CapitalYongjin CapitalNextLeap VenturesMagna Capital PartnersJohnson & Johnson Innovation
2019-04
A Round
$2.6M
★ Johnson & Johnson InnovationAxil CapitalScreen HoldingsNextLeap VenturesAMIT-Technion ( The Alfred Mann Institute)
2017-12
Seed
Undisclosed
★ NextLeap Ventures
2015-11
Grant
$800K
Headcount over time
From 4 (2018-07) to 27 (2026-07) · +23 (+575%) · 35 points · source: Finder history + radar grounding
Q&A
- What is Techsomed's primary focus?
- Techsomed specializes in ultrasound-based real-time monitoring systems for thermal ablation, leveraging generative AI to enhance ablation therapy for conditions like tumors, heart arrhythmias, and chronic pain.
- What is Techsomed's flagship product?
- Techsomed's flagship product is the BioTraceIO360 software suite, which focuses on liver tumor ablation procedures by providing tissue damage prediction, patient-specific treatment planning, and interactive ablation procedure analysis using standard medical imaging.
- Has Techsomed received any regulatory clearances for its products?
- Yes, Techsomed secured FDA De-Novo clearance for its post-ablation tissue response prediction offering, BioTrace, making it the first and only FDA-cleared solution of its kind. It also has a 510K clearance for ablation treatment planning and confirmation.
- Where are Techsomed's main operational centers located?
- Techsomed operates globally with its headquarters in Rehovot, Israel. It also maintains a subsidiary in Germany with an advanced R&D center and a subsidiary in Japan to support commercialization in Asian markets.
- When was Techsomed founded?
- Techsomed was founded in August 2012.
- How many employees does Techsomed have?
- Techsomed has 11-50 employees.
- What is Techsomed's total funding raised to date?
- Techsomed has raised a total of $12.9 million USD.
- When was Techsomed's most recent funding round?
- Techsomed's most recent funding round was a Grant in January 2024, with funding from the Israel Innovation Authority.
- Which investors participated in Techsomed's March 2021 funding round?
- The March 2021 funding round was led by Axil Capital, with participation from.
- Who is the CEO of Techsomed?
- Yossi Abu is the Founder & CEO of Techsomed.
Team · 2
Yossi Abu
Founder · CEO & Co-Founder
Eyal Melamed
Founder · Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
Platforms & InterfacesSoftware
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2BB2B2C
Highlights
1 PatentsVerified
Tags
bioconvergencehospitalsimage-processingminimally-invasivemonitoringreal-timeimagingultrasoundmedical-devices3d-technologyoncologycardiologydoctorshealthcare-providersclinicsdiagnosticsblood-pressurecancerdigital-healthcaredecision-supportsoftware-platform
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | techsomed.com |
|---|---|
| linkedin.com/company/8141297 |
Identifiers & details
| Legal name | Techsomed Medical Technologies Ltd. |
|---|---|
| Founded | 2012 |
| Employees (exact) | 27 |
Radar intelligence
Patents
| EPO | 3 |
|---|
Publications (Crossref)
| Works | 1 |
|---|
Web history (Wayback)
| Domain | techsomed.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514804343 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2012-08-01 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 11 — shares_capital (2), charge (4), violation (1), annual_report (3), people (1) |
| Registered address | עופרה חזה 6 אור יהודה |
Recent registry events
| Date | Event |
|---|---|
| 2026-04-29 | הקצאת מניות |
| 2025-08-28 | סילוק שעבוד |
| 2025-08-28 | סילוק שעבוד |
| 2025-08-28 | סילוק שעבוד |
| 2026-06-25 | עדכון הפרה |
| 2026-01-21 | העברת מניות |
| 2025-11-18 | דו~ח שנתי-הסרת בעל תפקיד |
| 2025-11-18 | דו~ח שנתי-עדכון כתובת |
| 2025-11-18 | דו~ח שנתי-הוספת בעל תפקיד |
| 2026-01-18 | עדכון בעלי תפקידים |
| 2025-09-02 | רישום שעבוד |